Is a complete SNOA research report available?

No complete published report is available for Sonoma Pharmaceuticals, Inc. (SNOA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Sonoma Pharmaceuticals, Inc. (SNOA)

NASDAQ: SNOA · USD

$1.15

+0.00 (0.0%)· Recorded snapshot

Market cap	5.5M
Revenue (ttm)	21.9M
Net income (ttm)	-2.3M
EPS (ttm)	-$1.01
Shares out	4.8M
Volume	49,465
Beta	1.30

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 21.9M
Net income (ttm): -2.3M
EPS (ttm): -$1.01
Market cap: 5.5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

Metric	Value
Amount currency	USD
CIK code	0001367083
Company name	Sonoma Pharmaceuticals, Inc.
Country	United States
Country code	US
CUSIP number	83558L303
Earnings date	2026-11-10
Earnings time	bmo
Employees	10
Employees change	2
Employees growth	25%
Enterprise value	$907,689
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	March
Founded	1999
Industry	Drug Manufacturers - Specialty & Generic
IPO date	2007-01-25
Is primary listing	Yes
Is SPAC	No
ISIN number	US83558L3033
Last 10-K release date	2026-06-16
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split date	2024-08-30
Last stock split type	Reverse
Market cap	$5.5M
Market cap category	Nano-Cap
Next earnings date	2026-11-10
Options	No
Price	$1.15
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	SNOA
U.S. state	Colorado
Website	https://sonomapharma.com

Metric

Value

Amount currency

USD

CIK code

0001367083

Company name

Sonoma Pharmaceuticals, Inc.

Country

United States

Country code

CUSIP number

83558L303

Earnings date

2026-11-10

Earnings time

bmo

Employees

Employees change

Employees growth

25%

Enterprise value

$907,689

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

March

Founded

1999

Industry

Drug Manufacturers - Specialty & Generic

IPO date

2007-01-25

Is primary listing

Yes

Is SPAC

ISIN number

US83558L3033

Last 10-K release date

2026-06-16

Last earnings date

2026-08-06

Last refreshed

2026-10-28

Last stock split date

2024-08-30

Last stock split type

Reverse

Market cap

$5.5M

Market cap category

Nano-Cap

Next earnings date

2026-11-10

Options

Price

$1.15

Price currency

USD

Sector

Healthcare

SIC code

3841

Stock price date

2026-10-28

Symbol

SNOA

U.S. state

Colorado

Website

https://sonomapharma.com

Metric	Value
Earnings yield	-88.07%
EV/Sales	0.04x
FCF / EV yield	-292.5%
FCF yield	-48.21%
Forward EV/Sales	0.06x
Forward P/S	0.33x
Industry forward P/E	13.86x
Industry P/E	173.47x
P/B ratio	0.83x
P/S ratio	0.25x
Price / tangible book value	0.84x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-88.07%

EV/Sales

0.04x

FCF / EV yield

-292.5%

FCF yield

-48.21%

Forward EV/Sales

0.06x

Forward P/S

0.33x

Industry forward P/E

13.86x

Industry P/E

173.47x

P/B ratio

0.83x

P/S ratio

0.25x

Price / tangible book value

0.84x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
EBIT margin	-6.41%
EBITDA margin	-5.8%
Gross margin	38.91%
Operating margin	-6.41%
Pretax margin	-11.44%
Profit margin	-10.33%
Profit per employee	$-226,400
Revenue per employee	$2.2M
ROA	-5.37%
ROA (5Y)	-16.89%
ROCE	-11.11%
ROE	-42.52%
ROE (5Y)	-70.56%
ROIC	-14.57%
SBC / revenue	1.17%
Tax / revenue	-1.11%

Metric

Value

EBIT margin

-6.41%

EBITDA margin

-5.8%

Gross margin

38.91%

Operating margin

-6.41%

Pretax margin

-11.44%

Profit margin

-10.33%

Profit per employee

$-226,400

Revenue per employee

$2.2M

ROA

-5.37%

ROA (5Y)

-16.89%

ROCE

-11.11%

ROE

-42.52%

ROE (5Y)

-70.56%

ROIC

-14.57%

SBC / revenue

1.17%

Tax / revenue

-1.11%

Metric	Value
EPS growth quarters	5
EPS growth years	8
Gross profit growth	51.66%
Gross profit growth (Q)	76.02%
Gross profit growth 3Y	28.33%
Gross profit growth 5Y	8.18%
Net income growth quarters	4
Net income growth years	3
Revenue growth	47%
Revenue growth (Q)	59.55%
Revenue growth (QoQ)	15.2%
Revenue growth 10Y	10.16%
Revenue growth 3Y	19.9%
Revenue growth 5Y	5.79%
Revenue growth quarters	8
Revenue growth years	2

Metric

Value

EPS growth quarters

EPS growth years

Gross profit growth

51.66%

Gross profit growth (Q)

76.02%

Gross profit growth 3Y

28.33%

Gross profit growth 5Y

8.18%

Net income growth quarters

Net income growth years

Revenue growth

47%

Revenue growth (Q)

59.55%

Revenue growth (QoQ)

15.2%

Revenue growth 10Y

10.16%

Revenue growth 3Y

19.9%

Revenue growth 5Y

5.79%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-88,000
Depreciation and amortization	$135,000
EBIT	$-1.4M
EBITDA	$-1.3M
EPS	$-1.01
FCF per share	$-0.55
Financing cash flow	$4M
Free cash flow	$-2.7M
Free cash flow minus SBC	$-2.9M
Gross profit	$8.5M
Income taxes	$-243,000
Investing cash flow	$-88,000
Net borrowing	$5,000
Net cash flow	$1.7M
Net income	$-2.3M
Operating cash flow minus SBC	$-2.8M
Operating income	$-1.4M
Revenue	$21.9M
Stock-based compensation	$256,000

Metric

Value

Capital expenditures

$-88,000

Depreciation and amortization

$135,000

EBIT

$-1.4M

EBITDA

$-1.3M

EPS

$-1.01

FCF per share

$-0.55

Financing cash flow

$4M

Free cash flow

$-2.7M

Free cash flow minus SBC

$-2.9M

Gross profit

$8.5M

Income taxes

$-243,000

Investing cash flow

$-88,000

Net borrowing

$5,000

Net cash flow

$1.7M

Net income

$-2.3M

Operating cash flow minus SBC

$-2.8M

Operating income

$-1.4M

Revenue

$21.9M

Stock-based compensation

$256,000

Metric	Value
Altman Z-Score	-13.61
Book value per share	$1.38
Debt / equity	0.11
Long-term assets	$1.8M
Long-term liabilities	$6.1M
Net cash (debt)	$4.6M
Net cash / market cap	83.52%
Net cash growth	56.96%
Net debt / equity	-0.7
Piotroski F-Score	3
Property, plant and equipment	$868,000
Shareholders' equity	$6.6M
Tangible book value	$6.6M
Tangible book value per share	$1.38
Total assets	$18.1M
Total cash	$5.3M
Total debt	$739,000
Total liabilities	$11.5M
WACC	10.07%

Metric

Value

Altman Z-Score

-13.61

Book value per share

$1.38

Debt / equity

0.11

Long-term assets

$1.8M

Long-term liabilities

$6.1M

Net cash (debt)

$4.6M

Net cash / market cap

83.52%

Net cash growth

56.96%

Net debt / equity

-0.7

Piotroski F-Score

Property, plant and equipment

$868,000

Shareholders' equity

$6.6M

Tangible book value

$6.6M

Tangible book value per share

$1.38

Total assets

$18.1M

Total cash

$5.3M

Total debt

$739,000

Total liabilities

$11.5M

WACC

10.07%

Metric	Value
Asset turnover	1.34
Current assets	$16.3M
Current liabilities	$5.4M
Current ratio	2.99
Inventory turnover	3.53
Net working capital	$5.8M
Quick ratio	1.56
Working capital	$10.8M
Working capital turnover	2.3

Metric

Value

Asset turnover

1.34

Current assets

$16.3M

Current liabilities

$5.4M

Current ratio

2.99

Inventory turnover

3.53

Net working capital

$5.8M

Quick ratio

1.56

Working capital

$10.8M

Working capital turnover

2.3

Metric	Value
Buyback yield / dilution	-55.39%
Dividend yield	0%
Shareholder yield	-55.39%

Metric

Value

Buyback yield / dilution

-55.39%

Dividend yield

Shareholder yield

-55.39%

Metric	Value
10Y price change	-99.84%
10Y return CAGR	-47.51%
10Y total return	-99.84%
150-day SMA	$1.34
15Y price change	-99.99%
15Y return CAGR	-44.97%
15Y total return	-99.99%
1D price change	0%
1M price change	-9.45%
1M total return	-9.45%
1W price change	0.88%
1W total return	0.88%
1Y price change	-71.25%
1Y return CAGR	-71.27%
1Y total return	-71.25%
20-day SMA	$1.17
200-day SMA	$1.73
3Y price change	-67.68%
3Y return CAGR	-31.37%
3Y total return	-67.68%
50-day SMA	$1.25
50-day SMA vs 200-day SMA	50under200
52-week high	$4.10
52-week high date	2025-10-29
52-week low	$0.85
52-week low date	2026-04-24
5Y price change	-99.05%
5Y return CAGR	-60.6%
5Y total return	-99.05%
6M price change	3.6%
6M total return	3.6%
All-time high	$72,323.40
All-time high date	2007-07-17
All-time low	$0.85
All-time low date	2026-04-24
Average true range (ATR)	$0.06
Average volume	38.9K
Beta (1Y)	2.2
Beta (2Y)	2.04
Beta (5Y)	1.3
Change from 52-week high	-71.95%
Change from 52-week low	35.28%
Change from all-time high	-100%
Change from all-time low	35.28%
Change from open	0%
Day's gap	0%
Dollar volume	$56,885
High price	$1.15
Low price	$1.15
Monthly RSI	31.17
Open price	$1.15
Premarket change	-1.74%
Premarket close	$1.15
Premarket price	$1.13
Previous close	$1.15
Price vs 150-day SMA	-14.18%
Price vs 20-day SMA	-2.04%
Price vs 200-day SMA	-33.37%
Price vs 50-day SMA	-7.93%
Relative volume	1.28
RSI	43.63
Sharpe ratio	-1.41
Sharpe ratio (3Y)	-0.02
Sharpe ratio (5Y)	-0.31
Sortino ratio	-1.71
Sortino ratio (3Y)	0.02
Sortino ratio (5Y)	-0.45
Volume	49.5K
Weekly RSI	35.04
YTD price change	-68.41%
YTD total return	-68.41%

Metric

Value

10Y price change

-99.84%

10Y return CAGR

-47.51%

10Y total return

-99.84%

150-day SMA

$1.34

15Y price change

-99.99%

15Y return CAGR

-44.97%

15Y total return

-99.99%

1D price change

1M price change

-9.45%

1M total return

-9.45%

1W price change

0.88%

1W total return

0.88%

1Y price change

-71.25%

1Y return CAGR

-71.27%

1Y total return

-71.25%

20-day SMA

$1.17

200-day SMA

$1.73

3Y price change

-67.68%

3Y return CAGR

-31.37%

3Y total return

-67.68%

50-day SMA

$1.25

50-day SMA vs 200-day SMA

50under200

52-week high

$4.10

52-week high date

2025-10-29

52-week low

$0.85

52-week low date

2026-04-24

5Y price change

-99.05%

5Y return CAGR

-60.6%

5Y total return

-99.05%

6M price change

3.6%

6M total return

3.6%

All-time high

$72,323.40

All-time high date

2007-07-17

All-time low

$0.85

All-time low date

2026-04-24

Average true range (ATR)

$0.06

Average volume

38.9K

Beta (1Y)

2.2

Beta (2Y)

2.04

Beta (5Y)

1.3

Change from 52-week high

-71.95%

Change from 52-week low

35.28%

Change from all-time high

-100%

Change from all-time low

35.28%

Change from open

Day's gap

Dollar volume

$56,885

High price

$1.15

Low price

$1.15

Monthly RSI

31.17

Open price

$1.15

Premarket change

-1.74%

Premarket close

$1.15

Premarket price

$1.13

Previous close

$1.15

Price vs 150-day SMA

-14.18%

Price vs 20-day SMA

-2.04%

Price vs 200-day SMA

-33.37%

Price vs 50-day SMA

-7.93%

Relative volume

1.28

RSI

43.63

Sharpe ratio

-1.41

Sharpe ratio (3Y)

-0.02

Sharpe ratio (5Y)

-0.31

Sortino ratio

-1.71

Sortino ratio (3Y)

0.02

Sortino ratio (5Y)

-0.45

Volume

49.5K

Weekly RSI

35.04

YTD price change

-68.41%

YTD total return

-68.41%

Metric	Value
Float	4.8M
Float percentage	99.58%
Shares change (QoQ)	121.67%
Shares change (YoY)	55.39%
Shares held by insiders	0.42%
Shares held by institutions	2.31%
Shares outstanding	4.8M
Short % of float	2.28%
Short % of shares	2.27%
Short ratio	3.1 days

Metric

Value

Float

4.8M

Float percentage

99.58%

Shares change (QoQ)

121.67%

Shares change (YoY)

55.39%

Shares held by insiders

0.42%

Shares held by institutions

2.31%

Shares outstanding

4.8M

Short % of float

2.28%

Short % of shares

2.27%

Short ratio

3.1 days

Sonoma Pharmaceuticals, Inc. (SNOA)

Price

Financial snapshot

Fair-value bridge

Latest news · SNOA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SNOA indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SNOA

Frequently asked questions